- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04889300
Resilience Factors and Selective Learning in Patients With Fibromyalgia
Learning impairments (such as reduced selective learning or excessive generalization) in the context of pain can lead to disability. Learning deficits have been found in experimental studies in various pain populations. In current scientific discussions, the activation of resilience factors (in particular positive affect and optimism) is being considered to optimize learning experiences and to make therapeutic procedures more effective. Positive affect could promote selective learning since positive emotions broaden attention and focus and thus possibly improve inhibitory learning. There is first scientific evidence for improved safety learning through positive affect in non-clinical samples in the context of pain. In this research project, the influence of positive affect and optimism on selective learning will be investigated in a clinical sample of fibromyalgia patients. Data will be collected online and standardized questionnaires will be used.
The authors expect that (1) There will be a larger increase in positive affect and positive future expectations in the Best Possible Self condition than in the Typical Day condition. (2) Patients in the Best Possible Self condition will show elevated positive affect and positive future expectations after the intervention compared to patients in the Typical Day condition. (3) And crucially, patients in the Best Possible Self condition will show better selective learning than patients in the Typical Day group. Thus the investigators hypothesize that the blocking effect will be higher for patients with higher degrees of positive affect and optimism.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Selective learning will be experimentally investigated by using the blocking procedure. The blocking effect is one mechanism that can provide information about selective learning. In this procedure, one event (A+) will be first paired with pain. Participants should learn the relation between this event and the occurrence of pain. After, another event (x), i.e. the blocking stimulus, is displayed with the first event A (AX+). The combination of both events will also be associated with pain. It will be tested, to which extent participants expect pain for the blocking stimulus alone. In case of "blocked", i.e. reduced pain expectation for X we can assume adaptive, selective learning.
In the planned study a fictitious diary of a fibromyalgia patient will be used as "cover story". Different events and the words "pain" or "no pain" will be visually presented together, indicating in which situation pain occurs and in which not. Participants will be asked to imagine that they are the practitioner trying to learn which situations are associated with pain. This learning experiment is based on a former study by Meulders and colleagues, in which selective learning was investigated by presenting fictitious diary entries, such as "Kim was walking her dog" or "the weather was bad today" (CS) and pairing the sentences in terms of the blocking procedure (see above). In the central test phase, in which events were presented without pain report, participants were asked to give their pain expectations for the different situations. Deficits in selective learning were found in fibromyalgia patients compared to healthy control. For the planned study this learning paradigm will be used with minor adaptations (translated to German, minor instruction adaptations, renamed scale ends, higher scale resolution). The learning experiment will take about 15 minutes.
Positive affect and optimism will be induced through the Best Possible Self (BPS) Intervention. Subjects will be randomly assigned to either the optimism condition or a control condition.
The whole study will be conducted online. Participants will be asked to switch from the experimental platform to the questionnaire platform at various times. In order to recreate the laboratory situation and to keep participants engaged, we implemented several videos in which the virtual investigator guides participants throughout the experiment.
The sample size should include 164 participants, assuming a small effect. A priori power analyses were calculated with the software program G*Power for ANOVA with repeated measures, within-between interaction with a small effect (f=0.1, Power 0.8, α=0.05).
Patients with fibromyalgia will be recruited via social media platforms like Facebook and Instagram, but also through advertisement in magazines, self-help groups as well as via flyers in medical offices and clinics.
Mainly ANOVA´s with repeated measures and t-tests are planned to be calculated. There will be four separate repeated measures (RM) ANOVA´s on positive and negative Affect and on positive and negative future expectations with Group (BPS/TD) as between-factor and Time (Pre/Post) as within-subjects factor. Planned contrasts will also be used to check whether the increase in a) positive affect and b) positive future expectations (and not a decrease in a) negative affect and b) negative future expectations) will be larger in the BPS group compared with the TD group.
Further, we will calculate ANOVA´s to test acquisition of pain expectancy in the different phases. The central analysis will be a 2 x 3 RM ANOVA with Group (BPS/TD) as between-subjects variable and Stimulus Type (B/Z/X) as within-subjects variable on pain expectancy ratings in the test phase of the learning experiment. Further, following the literature, the investigators might do responder analyses and use the change in a) positive affect and b) positive future expectations as predictors for selective learning (in order to have more power in statistical analyses, if necessary).
Transformations: Transformations of not normally distributed variables will be done.
Inference criteria: We will use the standard p < .05 criteria.
Data exclusion: Participants will be excluded from analyses, if they give Z>X ratings in the test phase or if they give the same rating throughout the whole experiment. Participants, who did not complete the BPS/TD writing exercise properly will be excluded from ANOVA´s with group factors.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Marburg, Germany
- Philipps University Marburg Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- self-reported fibromyalgia diagnosis
- access to a computer or laptop with audio output
Exclusion Criteria:
- dyslexia
- other impairments that affect cognitive performance (e.g. stroke or brain damages)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Best Possible Self
Positive affect and optimism will be induced through the Best Possible Self (BPS) Intervention.
In the optimism intervention, participants will be asked to imagine a future in which everything went well and in which all their wishes are fulfilled.
This procedure is known to reliably generate positive affect and positive future expectations (Carrillo et al., 2019).
Orientated at Flink et al. (2015) the BPS condition was adapted for a pain population.
|
Participants are asked to think about their Best Possible Self for one minute, then describe it for 15 minutes (in writing) and, subsequently, imagine it for another 5 minutes as vividly as possible.
|
|
Active Comparator: Typical Day
In the control condition, participants are asked to describe and visualize a typical day (TD).
We adapted the TD condition in order to take possible changes in participants´ TD due to the COVID-19 pandemic into account.
|
Participants are asked to think about their Typical Day for one minute, then describe it for 15 minutes (in writing) and, subsequently, imagine it for another 5 minutes as vividly as possible.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Positive Affect
Time Frame: post-intervention (immediately after the intervention)
|
Positive Affect will be measured with the Positive and Negative Affect Schedule (PANAS; Breyer & Bluemke, 2016).
It will be tested if participants of the BPS group score higher in Positive Affect after the intervention than at baseline.
Further, we will test if participants in the BPS condition score higher in Positive Affect than participants in the TD group.
|
post-intervention (immediately after the intervention)
|
|
State Optimism/Positive Future Expectancies
Time Frame: post-intervention (immediately after the intervention)
|
State Optimism/Positive Future Expectancies will be measured with the future expectancies scale (FEX; Hanssen et al., 2013; Peters, Vieler, & Lautenbacher, 2016). It will be tested if participants of the BPS group score higher in Optimism after the intervention than at baseline. Further, we will test if participants in the BPS condition score higher in Optimism than participants in the TD group. |
post-intervention (immediately after the intervention)
|
|
Pain expectancy/contingency awareness pre-rating phase
Time Frame: Pain-expectancy will be measured in the pre-rating phase before the intervention
|
Numerical Rating Scale (NRS; 0-100; 0 = expect not all, 100 = expect very much) It will be tested to which extent participants expect pain for the different stimuli which are used in the experiment (A, B, X, Z).
|
Pain-expectancy will be measured in the pre-rating phase before the intervention
|
|
Pain expectancy/contingency awareness elemental acquisition phase
Time Frame: Pain-expectancy will be measured in the practice phase before the intervention
|
Numerical Rating Scale (NRS; 0-100; 0 = expect not all, 100 = expect very much) It will be tested to which extent participants expect pain for the stimuli A+ and Z-.
|
Pain-expectancy will be measured in the practice phase before the intervention
|
|
Pain expectancy/contingency awareness reminder of acquisition phase
Time Frame: post-intervention (immediately after the intervention)
|
Numerical Rating Scale (NRS; 0-100; 0 = expect not all, 100 = expect very much) It will be tested to which extent participants expect pain for the stimuli A+ and Z-.
|
post-intervention (immediately after the intervention)
|
|
Pain expectancy/contingency awareness compound acquisition phase
Time Frame: post-intervention (immediately after the intervention)
|
Numerical Rating Scale (NRS; 0-100; 0 = expect not all, 100 = expect very much) It will be tested to which extent participants expect pain for the stimuli B+, AX+ and Z-.
|
post-intervention (immediately after the intervention)
|
|
Pain expectancy/contingency awareness test phase
Time Frame: post-intervention (immediately after the intervention)
|
Numerical Rating Scale (NRS; 0-100; 0 = expect not all, 100 = expect very much) It will be tested to which extent participants expect pain for X, B, and Z.
In case of "blocked", i.e. reduced pain expectation for X in the test phase we can assume adaptive, selective learning.
|
post-intervention (immediately after the intervention)
|
|
Positive Affect
Time Frame: immediately after the blocking procedure
|
Positive Affect will be measured with the Positive and Negative Affect Schedule (PANAS; Breyer & Bluemke, 2016).
It will be tested if affect is stable from immediate postvisualization to end of the experiment.
|
immediately after the blocking procedure
|
|
State Optimism/Positive Future Expectancies
Time Frame: immediately after the blocking procedure
|
State Optimism/Positive Future Expectancies will be measured with the future expectancies scale (FEX; Hanssen et al., 2013; Peters, Vieler, & Lautenbacher, 2016). It will be tested if state optimism is stable from immediate postvisualization to end of the experiment. |
immediately after the blocking procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Trait Optimism
Time Frame: pre-intervention (baseline)
|
Trait Optimism will be measured with the revised version of the life-orientation-test (LOT-R; Scheier & Carver 1985).
|
pre-intervention (baseline)
|
|
chronic pain
Time Frame: immediately after the blocking procedure
|
Pain will be measured with the revised graded chronic pain scale (GCPS-R, von Korff et al., 2020).
|
immediately after the blocking procedure
|
|
Depression
Time Frame: immediately after the blocking procedure
|
Depression will be measured with the Patient Health Questionnaire (PHQ-9, Spitzer, Kroenke & Williams, 1999).
|
immediately after the blocking procedure
|
|
Pain Catastrophizing
Time Frame: immediately after the blocking procedure
|
Pain Catastrophizing will be measured with the Pain Catastrophizing Scale (PCS; Sullivan, Bishop, Pivik 1995).
Answers are scored on a 5-point rating scale (0 = not at all; 4 = all the time).
|
immediately after the blocking procedure
|
|
Negative Affect
Time Frame: post-intervention (immediately after the intervention)
|
Negative Affect will be measured with the Positive and Negative Affect Schedule (PANAS; Breyer & Bluemke, 2016).
It will be tested if participants´ scores in Negative Affect are influenced by the intervention.
|
post-intervention (immediately after the intervention)
|
|
Negative Affect
Time Frame: immediately after the blocking procedure
|
Negative Affect will be measured with the Positive and Negative Affect Schedule (PANAS; Breyer & Bluemke, 2016).
It will be tested if Negative Affect is stable from immediate postvisualization to end of the experiment.
|
immediately after the blocking procedure
|
|
Negative Future Expectancies
Time Frame: immediately after the blocking procedure
|
Negative Future Expectancies will be measured with the future expectancies scale (FEX; Hanssen et al., 2013; Peters, Vieler, & Lautenbacher, 2016).It will be tested if participants´ score in Negative Future Expectancies are influenced by the intervention.
|
immediately after the blocking procedure
|
|
Negative Future Expectancies
Time Frame: post-intervention (immediately after the intervention)
|
Negative Future Expectancies will be measured with the future expectancies scale (FEX; Hanssen et al., 2013; Peters, Vieler, & Lautenbacher, 2016).It will be tested if participants´ score in Negative Future Expectancies are influenced by the intervention.
|
post-intervention (immediately after the intervention)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain expectancy/contingency awareness practice phase
Time Frame: Pain-expectancy will be measured in the practice phase before the intervention
|
Participants can train to give pain expectancy ratings for the stimuli C+ und D-, which are only used in the practice phase.
|
Pain-expectancy will be measured in the practice phase before the intervention
|
|
Positive Affect
Time Frame: pre-intervention (baseline)
|
Positive Affect will be measured with the Positive and Negative Affect Schedule (PANAS; Breyer & Bluemke, 2016).
It will be tested if there are baseline differences between the BPS and TD group.
Further, this outcome might be used as covariate.
|
pre-intervention (baseline)
|
|
State Optimism/Positive Future Expectancies
Time Frame: pre-intervention
|
State Optimism/Positive Future Expectancies will be measured with the future expectancies scale (FEX; Hanssen et al., 2013; Peters, Vieler, & Lautenbacher, 2016). It will be tested if there are baseline differences between the BPS and TD group. Further, this outcome might be used as a covariate. |
pre-intervention
|
|
Negative Future Expectancies
Time Frame: pre-intervention (baseline)
|
Negative Future Expectancies will be measured with the future expectancies scale (FEX; Hanssen et al., 2013; Peters, Vieler, & Lautenbacher, 2016).It will be tested if participants´ score in Negative Future Expectancies are influenced by the intervention.
|
pre-intervention (baseline)
|
|
Negative Affect
Time Frame: pre-intervention
|
Negative Affect will be measured with the Positive and Negative Affect Schedule (PANAS; Breyer & Bluemke, 2016).
It will be tested if there are baseline differences between the BPS and TD group.
|
pre-intervention
|
Collaborators and Investigators
Investigators
- Principal Investigator: Winfried Rief, Professor, Philipps University Marburg Medical Center
Publications and helpful links
General Publications
- Meevissen YM, Peters ML, Alberts HJ. Become more optimistic by imagining a best possible self: effects of a two week intervention. J Behav Ther Exp Psychiatry. 2011 Sep;42(3):371-8. doi: 10.1016/j.jbtep.2011.02.012. Epub 2011 Mar 2.
- Vlaeyen JWS, Linton SJ. Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain. 2000 Apr;85(3):317-332. doi: 10.1016/S0304-3959(99)00242-0.
- Boselie JJ, Vancleef LM, Peters ML. Increasing Optimism Protects Against Pain-Induced Impairment in Task-Shifting Performance. J Pain. 2017 Apr;18(4):446-455. doi: 10.1016/j.jpain.2016.12.007. Epub 2016 Dec 27.
- Boselie JJLM, Vancleef LMG, Smeets T, Peters ML. Increasing optimism abolishes pain-induced impairments in executive task performance. Pain. 2014 Feb;155(2):334-340. doi: 10.1016/j.pain.2013.10.014. Epub 2013 Oct 19.
- Flink IK, Reme S, Jacobsen HB, Glombiewski J, Vlaeyen JWS, Nicholas MK, Main CJ, Peters M, Williams ACC, Schrooten MGS, Shaw W, Boersma K. Pain psychology in the 21st century: lessons learned and moving forward. Scand J Pain. 2020 Apr 28;20(2):229-238. doi: 10.1515/sjpain-2019-0180.
- Flink IK, Smeets E, Bergboma S, Peters ML. Happy despite pain: Pilot study of a positive psychology intervention for patients with chronic pain. Scand J Pain. 2015 Apr 1;7(1):71-79. doi: 10.1016/j.sjpain.2015.01.005.
- Geschwind N, Meulders M, Peters ML, Vlaeyen JW, Meulders A. Can experimentally induced positive affect attenuate generalization of fear of movement-related pain? J Pain. 2015 Mar;16(3):258-69. doi: 10.1016/j.jpain.2014.12.003. Epub 2014 Dec 20.
- Harvie DS, Weermeijer JD, Olthof NA, Meulders A. Learning to predict pain: differences in people with persistent neck pain and pain-free controls. PeerJ. 2020 Jun 23;8:e9345. doi: 10.7717/peerj.9345. eCollection 2020.
- Meulders A. Fear in the context of pain: Lessons learned from 100 years of fear conditioning research. Behav Res Ther. 2020 Aug;131:103635. doi: 10.1016/j.brat.2020.103635. Epub 2020 Apr 30.
- Meulders A, Boddez Y, Blanco F, Van Den Houte M, Vlaeyen JWS. Reduced selective learning in patients with fibromyalgia vs healthy controls. Pain. 2018 Jul;159(7):1268-1276. doi: 10.1097/j.pain.0000000000001207.
- Meulders A, Harvie DS, Bowering JK, Caragianis S, Vlaeyen JW, Moseley GL. Contingency learning deficits and generalization in chronic unilateral hand pain patients. J Pain. 2014 Oct;15(10):1046-56. doi: 10.1016/j.jpain.2014.07.005. Epub 2014 Jul 25.
- Meulders A, Meulders M, Vlaeyen JW. Positive affect protects against deficient safety learning during extinction of fear of movement-related pain in healthy individuals scoring relatively high on trait anxiety. J Pain. 2014 Jun;15(6):632-44. doi: 10.1016/j.jpain.2014.02.009. Epub 2014 Mar 17.
- Vlaeyen JWS, Linton SJ. Fear-avoidance model of chronic musculoskeletal pain: 12 years on. Pain. 2012 Jun;153(6):1144-1147. doi: 10.1016/j.pain.2011.12.009. Epub 2012 Feb 8. No abstract available.
- Zbozinek TD, Craske MG. The Role of Positive Affect in Enhancing Extinction Learning and Exposure Therapy for Anxiety Disorders. Journal of Experimental Psychopathology. April 2017:13-39. doi:10.5127/jep.052615
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BRF0421
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fibromyalgia
-
Ionclinics & Deionic SLHospital Clínico Universitario de ValenciaNot yet recruitingFibromyalgia (FM)Spain
-
Ain Shams UniversityRecruiting
-
Selcuk UniversityNot yet recruiting
-
Fundació Institut de Recerca de l'Hospital de la...CompletedFibromyalgia (FM)Spain
-
Istanbul Gelisim UniversityBahçeşehir UniversityCompleted
-
Gazi UniversityCompletedFibromyalgia SyndromeTurkey (Türkiye)
-
University of UtahRecruitingFibromyalgia (FM)United States
-
María Catalina Osuna PérezActive, not recruitingFibromyalgia SyndromeSpain
-
Istanbul UniversityCompletedFibromyalgia | Fibromyalgia Syndrome | Fibromyalgia (FM)Turkey (Türkiye)
Clinical Trials on Best Possible Self
-
Liverpool John Moores UniversityCompletedDiabetes Mellitus, Type 2United Kingdom
-
University of OregonNational Institute of Mental Health (NIMH)Enrolling by invitation
-
Universitat Jaume IUnknown
-
Universitat Jaume IHospital Provincial de Castellon; PREVI Clinical CenterCompletedEating Disorder | Daily ActivitiesSpain
-
Universitat Jaume ICompleted
-
Yale UniversityCompletedBinge-Eating Disorder | Overweight or Obesity | Binge EatingUnited States
-
McGill UniversityCanadian Stroke NetworkCompleted
-
Bispebjerg HospitalCompleted
-
University Health Network, TorontoThe Weston A. Price FoundationRecruitingChronic Traumatic EncephalopathyCanada
-
University of Wisconsin, MadisonLoyola University Chicago; Iowa State UniversityCompletedParent-Child Relations